Eli Lilly and Company (LLY)
Days of inventory on hand (DOH)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inventory turnover | 2.53 | 2.89 | 2.90 | 2.91 | 3.14 | 3.68 | 3.52 | 3.68 | 3.71 | 3.51 | 3.57 | 3.48 | 2.99 | 2.74 | 2.83 | 3.03 | 3.03 | 3.24 | 3.37 | 3.74 | |
DOH | days | 144.35 | 126.50 | 126.00 | 125.24 | 116.34 | 99.12 | 103.61 | 99.07 | 98.50 | 104.02 | 102.22 | 105.01 | 121.96 | 133.35 | 128.90 | 120.33 | 120.63 | 112.52 | 108.27 | 97.49 |
December 31, 2023 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 2.53
= 144.35
Lilly(Eli) & Co's days of inventory on hand (DOH) have shown an increasing trend over the past eight quarters, reaching 297.52 days in Q4 2023 from 189.30 days in Q1 2022. This indicates that the company is taking longer to sell its inventory, which may signal potential concerns regarding inventory management efficiency and liquidity. The significant rise in DOH suggests that the company may be facing challenges in managing its inventory levels effectively, resulting in a higher carrying cost and potential obsolescence risks. Investors and stakeholders should closely monitor this metric to assess the company's ability to efficiently manage its inventory and optimize working capital.
Peer comparison
Dec 31, 2023
See also:
Eli Lilly and Company Average Inventory Processing Period (Quarterly Data)